脑部放疗,上午比下午敏感许多! ^8 N5 c1 l, U U9 x! `# U- Y- Y
; W9 u, j) j5 b: i" s
- F9 E" f2 W" r# G, i0 Z/ |7 z
Cancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9., f, P8 l9 r! g! g
Gamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?
& N3 u- n2 q7 R8 SRahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.# f J* K1 V9 q
SourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.
" U+ g- _5 a1 y2 }+ M e0 Q( l0 t0 [% G) l0 y( b
Abstract5 y. f5 C. k7 _% N
BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.
+ k- ~7 c+ F7 b3 B$ I' d% h9 W
$ ^9 f! m4 K, z+ PMETHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.
, F5 d& m; I' H. C0 B+ Q" i* G7 f- i% U
RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026)., f- W+ C. ~) _% E" \1 y
4 w0 F/ b$ L; z/ |( J/ sCONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.' r5 d: `4 q# m8 t; C+ u. ]4 J$ ?
) d& N# j) z$ ?# R( D5 w) n- h0 G
|